MENU

【2026年】研究成果

書籍

※準備中※


雑誌

 著者氏名  論文タイトル名

 発表誌名  

巻号ページ
本村政勝,池浩司,北之園寛子,清水悦郎,吉村俊介,山田昌司,畑中裕己,入江隆どうすればランバート・イートン筋無力症候群患者を早期に診断できるか？：日本人症例報告のシステマティックレビュー
BRAIN and NERVE 　　　　　　　　　                                         78巻2号 　　　177-186                                       　
Shinoda K, Matsuyoshi A, Takeuchi H, Watanabe M, Masaki K, Igeta E, Kamano H, Yamashita K, Togao O, Isobe. N Diagnostic performance of central vein sign, paramagnetic rim lesion, and cortical lesion in Asian patients with multiple sclerosis. Mult Scler J 32 385-395                                              　　
Matsuyoshi A, Shinoda K, Takeuchi H, Mizutani K, Kira Y, Iwao K, Watanabe M, Masaki K, Isobe N. The real-world experience of biologics for neuromyelitis optica spectrum disorders as first-line and switched therapy. J Neuroimmunol. 410 578799　　　　
Kira JI, Zhang X, Fujii T, Mitsuishi M, Ushijima M, Yoshidomi S, Sakoda A, Imamura T, Kuwabara S, Isobe N, Nakamura Y. Nationwide Survey of Atopic Myelitis and Plexin D1-Immunoglobulin G-Related Pain. Ann Clin Transl Neurol. 
13 593-606
Handa H, Uzawa A, Shibuya K, Kojima Y, Suichi T, Yasuda M, Yoshimura S, Motomura M, Kuwabara SDiagnosis of Lambert-Eaton myasthenic syndrome: Muscle fatigue with normal manual muscle testing, areflexia, and electrodiagnostic findings. J Neuroimmunol.  417 578917 
Yasuda M, Uzawa A, Ogaya E, Handa H, Kurumada K, Takasaka K, Akamine H, Ozawa Y, Kuwabara SLongitudinal MuSK antibody levels may correlate with disease severity in MuSK myasthenia gravis. J Neuroimmunol.  414 578876 
akeuchi H Differences in COVID-19 Vaccine Efficacy Among Types of B‐Cell Depletion Therapy Clin Exp Neuroimmunol 16(5) 374-375　　　　　
Takeuchi H, Miyazaki Y, Kiriyama T, Fukaura H, Fujimori J, Masaki K, Misawa S, Miyamoto K, Yoshikura N, Ukita S, Nagashima K, Nakashima I The Japan Neuromyelitis Optica Spectrum Disorders/Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease RegistryClin Exp Neuroimmunol17(1) e70023 
Miyazaki Y, Takeuchi H, Kiriyama T, Fukaura H, Fujimori J, Masaki K, Misawa S, Miyamoto K, Yoshikura N, Ukita S, Nagashima K, Nakashima I The Japan Neuromyelitis Optica Spectrum Disorders/Myelin Oligodendrocyte Glycoprotein Antibody‐Associated Disease Registry: Background Analysis of the Initial 116 Cases Clin Exp Neuroimmunol 17(1) e70032
Miyazaki Y, Niino M, et al. Wearable-based physiological monitoring and brain magnetic resonance imaging metrics in multiple sclerosis: A feasibility study. J Neuroimmunol 410 578819 　
Shimizu Y, Nakashima I, Ikeguchi R, Nagatsuka T, Yamashita K, Fukuoka Y, Murata T, Fujihara K Impact of Symptoms of Neuromyelitis Optica Spectrum Disorder and Patient‐Determined Oral Glucocorticoid–Related Adverse Events on Patients' Daily Living and Emotions: A Qualitative Analysis From JapanClin Exp Neuroimmunol 17 e70026
Ueda H, Kubota T, Goto R, Suzuki A, Ojima T, Ogawa K, Sonehara K, Namba S, Naito T, Wang Q, Konno S, Samukawa M, Kawaguchi N, Kimura T, Sugimoto T, Murai H, Yamawaki T, Kaida K, Tokuyasu D, Yasuda M, Akamine H, Onishi Y, Ogawa Y, Shirai Y, Edahiro R, Yamamoto K, Nagata H, Ose N, Takayama J, Suzuki K, Higashiue S, Kobayashi S, Yamaguchi H, Okazaki Y, Matsumoto N, Motomura K, Koga H, Matsuda K, Tamiya G, Yamamoto M, Yamauchi T, Kadowaki T, Yamamoto K, Ohno A, Okuno T, Morii E, Mochizuki H, Nagane Y, Minami N, Uzawa A, Masuda M, Suzuki S, Shimomura I, Shintani Y, Utsugisawa K, Takahashi MP, Okada Y.Elucidating genetic backgrounds of myasthenia gravis in Japanese by genome-wide association studies and multi-omics analyses of thymoma. Nature Communicatioーテキスト